Gene · 3376
Papers2,904
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,904
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cardiomyocyte-Specific Loss of Glutamyl-prolyl-tRNA Synthetase Leads to Disturbed Protein Homeostasis and Dilated Cardiomyopathy. | Cells | 2023 | 38201239 | PubTator, text mining | PubMed |
| 'Oxidative stress'-A new target in the management of diabetes mellitus. | J Family Med Prim Care | 2023 | 38186790 | PubTator, text mining | PubMed |
| Stage-specific treatment of colorectal cancer: A microRNA-nanocomposite approach. | J Pharm Anal | 2023 | 38174117 | PubTator, text mining | PubMed |
| Diabetes and diabesity in the view of proteomics, drug, and plant-derived remedies. | J Res Med Sci | 2023 | 38152069 | PubTator, text mining | PubMed |
| Sex hormone-binding globulin improves lipid metabolism and reduces inflammation in subcutaneous adipose tissue of metabolic syndrome-affected horses. | Front Mol Biosci | 2023 | 38146533 | PubTator, text mining | PubMed |
| Molecular Mechanisms Linking Diabetes with Increased Risk of Thrombosis. | Int J Mol Sci | 2023 | 38139295 | PubTator, text mining | PubMed |
| The Profiling of 179 miRNA Expression in Serum from Limb Girdle Muscular Dystrophy Patients and Healthy Controls. | Int J Mol Sci | 2023 | 38139231 | PubTator, text mining | PubMed |
| Drug Therapies for Diabetes. | Int J Mol Sci | 2023 | 38138975 | PubTator, text mining | PubMed |
| BACH1 controls hepatic insulin signaling and glucose homeostasis in mice. | Nat Commun | 2023 | 38129407 | PubTator, text mining | PubMed |
| Anti-EJ antibody-positive interstitial pneumonia with breast cancer improved by combining immunosuppressive therapy and chemotherapy. | Respir Med Case Rep | 2023 | 38124994 | PubTator, text mining | PubMed |
| Aminoacyl-tRNA synthetase interactions in SARS-CoV-2 infection. | Biochem Soc Trans | 2023 | 38108455 | PubTator, text mining | PubMed |
| Translation inhibition efficacy does not determine the Plasmodium berghei liver stage antiplasmodial efficacy of protein synthesis inhibitors. | bioRxiv | 2023 | 38106175 | PubTator, text mining | PubMed |
| Cellular and molecular overview of gestational diabetes mellitus: Is it predictable and preventable? | World J Diabetes | 2023 | 38077798 | PubTator, text mining | PubMed |
| A comprehensive review of the novel therapeutic targets for the treatment of diabetic cardiomyopathy. | Ther Adv Cardiovasc Dis | 2023 | 38069578 | PubTator, text mining | PubMed |
| FARSB Facilitates Hepatocellular Carcinoma Progression by Activating the mTORC1 Signaling Pathway. | Int J Mol Sci | 2023 | 38069034 | PubTator, text mining | PubMed |
| Genetic and Epigenetic Factors in Gestational Diabetes Mellitus Pathology. | Int J Mol Sci | 2023 | 38068941 | PubTator, text mining | PubMed |
| Trends in Oxidative Balance Score and Prevalence of Metabolic Dysfunction-Associated Steatotic Liver Disease in the United States: National Health and Nutrition Examination Survey 2001 to 2018. | Nutrients | 2023 | 38068789 | PubTator, text mining | PubMed |
| Isthmin-1 (ISM1), a novel adipokine that reflects abdominal adipose tissue distribution in individuals with obesity. | Cardiovasc Diabetol | 2023 | 38066623 | PubTator, text mining | PubMed |
| Identification of potential immune-related hub genes in Parkinson's disease based on machine learning and development and validation of a diagnostic classification model. | PLoS One | 2023 | 38051734 | PubTator, text mining | PubMed |
| The Efficacy and Safety of Myo-inositol Supplementation for the Prevention of Gestational Diabetes Mellitus in Overweight and Obese Pregnant Women: A Systematic Review and Meta-Analysis. | J ASEAN Fed Endocr Soc | 2023 | 38045667 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3376/papers?page=12